![]() |
市场调查报告书
商品编码
1946057
全球小型动物专科医疗保健市场:预测(至2034年)-依动物种类、专科医疗保健类型、服务类型、设施类型、最终使用者和地区进行分析Small Animal Specialty Care Market Forecasts to 2034 - Global Analysis By Animal Type (Dogs, Cats, Other Small Animals), Specialty Care Type, Service Type, Facility Type, End User and By Geography |
||||||
根据 Stratistics MRC 的研究,预计到 2026 年,全球小动物专科医疗保健市场将达到 1,677 亿美元,并在预测期内以 7.5% 的复合年增长率增长,到 2034 年达到 2,991 亿美元。
小动物专科医疗是指专注于诊断、治疗和长期管理伴侣动物(如犬、猫和其他小型宠物)复杂健康问题的高级兽医服务。这些服务由专业认证的兽医专科医生提供,涵盖心臟病学、肿瘤学、神经病学、整形外科、皮肤病学和内科等多个领域。这些服务运用专业的诊断工具、先进的影像技术、外科手术和实证治疗方法,通常透过转诊中心和专科医院提供,从而确保全面、高品质的患者照护。
宠物主人数量的增加和宠物拟人化
全球宠物饲养量的成长以及宠物人性化趋势的日益盛行,是推动小型动物专科兽医市场发展的主要因素。饲主越来越将宠物视为家庭成员,并愿意投资先进的治疗方法来改善它们的生命品质并延长其寿命。这种转变促使饲主要求与人类医疗保健服务相媲美的全面、高品质的护理,从而增加了对肿瘤科、心臟科和皮肤科等专科兽医服务的需求。这正在推动市场扩张。
专业兽医护理高成本
小型动物专科兽医护理的高昂费用仍然是阻碍因素。先进的诊断技术、专业的外科手术以及由认证兽医进行的治疗都会显着增加整体治疗成本。这些费用可能会限制人们获得兽医服务的机会,尤其是在价格敏感地区和没有宠物保险的饲主中。儘管人们的意识正在提高,但成本方面的挑战仍然阻碍了专科服务的广泛普及,尤其是在宠物保险普及率较低的新兴市场。
兽医学进展
兽医学的持续进步为市场带来了巨大的成长机会。影像学、微创手术、再生医学和标靶治疗领域的创新正在改善复杂动物疾病的治疗效果。此外,数位健康工具、远距医疗和人工智慧辅助诊断的整合正在提高临床效率和准确性。这些进步正在拓展专科医疗服务的范围,并推动兽医专业人员和宠物饲主对这些技术的接受度不断提高。
监理和合规挑战
监管和合规方面的挑战对小型动物专科兽医市场构成重大威胁。兽医机构必须遵守有关医疗程序、药物使用、资料管理和动物福利的严格标准,而这些标准可能因地区而异。频繁的监管更新增加了专科医院营运的复杂性和合规成本。未能满足这些要求可能会导致罚款和服务限制,这可能会阻碍市场扩张和跨国服务提供。
新冠疫情对小型动物专科兽医市场产生了复杂的影响。虽然最初的封锁措施扰乱了人们前往兽医诊所就诊和进行择期手术,但疫情也促使宠物领养数量增加,并提高了人们对宠物健康的关注度。随着时间的推移,在治疗延期和宠物饲养量增加的推动下,对专科兽医服务的需求强劲復苏。兽医诊所转向远端医疗并加强了安全措施,加速了专科兽医生态系统的数位转型。
在预测期内,皮肤科领域预计将占据最大的市场份额。
预计在预测期内,皮肤病学领域将占据最大的市场份额。这主要是由于伴侣动物皮肤相关疾病的高发生率。过敏、感染疾病、寄生虫感染和慢性皮肤病在犬猫中十分常见,需要频繁就诊。人们对皮肤病的认识不断提高、诊断能力不断增强以及先进的局部和全身疗法的广泛应用,进一步巩固了该领域在专科兽医学中的主导地位。
预计在预测期内,外科手术服务业将呈现最高的复合年增长率。
在预测期内,外科服务业预计将呈现最高的成长率,这主要得益于对先进微创手术需求的不断增长。手术器械、麻醉和术后护理技术的进步提高了安全性和治疗效果,从而支撑了这一增长。此外,小型动物创伤、整形外科疾病、癌症和先天性异常病例的增加也促进了专业外科手术的普及。
在预测期内,北美预计将保持最大的市场份额,这主要得益于其较高的宠物拥有率、完善的兽医基础设施以及先进的专业服务普及率。大型动物医院的存在、众多认证专家的涌现以及宠物饲主较高的健康意识,都巩固了其市场主导地位。此外,该地区优惠的宠物保险覆盖范围和较高的可支配收入水准也进一步推动了对高端专业兽医服务的需求。
在预测期内,亚太地区预计将呈现最高的复合年增长率,这主要得益于快速的都市化、宠物饲养量的增加以及可支配收入的增长。人们对动物健康的日益关注、专业兽医诊所的扩张以及先进医疗技术的普及,都在推动市场成长。此外,人们对宠物的文化态度转变以及对兽医基础设施投资的增加,也加速了全部区域小型动物专业兽医服务的普及。
According to Stratistics MRC, the Global Small Animal Specialty Care Market is accounted for $167.7 billion in 2026 and is expected to reach $299.1 billion by 2034 growing at a CAGR of 7.5% during the forecast period. Small Animal Specialty Care refers to advanced veterinary medical services focused on the diagnosis, treatment, and long-term management of complex health conditions in companion animals such as dogs, cats, and other small pets. It is delivered by board-certified veterinary specialists across disciplines including cardiology, oncology, neurology, orthopedics, dermatology, and internal medicine. These services employ specialized diagnostic tools, advanced imaging, surgical interventions, and evidence-based therapies, typically provided through referral centers or specialty hospitals to support comprehensive, high-quality patient care.
Rising pet ownership and humanization of pets
The growing global pet population, coupled with the increasing humanization of companion animals, is a major driver of the small animal specialty care market. Pet owners increasingly view animals as family members and are willing to invest in advanced medical treatments to enhance quality of life and longevity. This shift has led to higher demand for specialized veterinary services, including oncology, cardiology, and dermatology, as owners seek comprehensive, high-standard care comparable to human healthcare services. Thus, it drives market expansion.
High cost of specialty veterinary care
The high cost associated with small animal specialty care remains a key restraint for market growth. Advanced diagnostics, specialized surgical procedures, and treatment by board-certified veterinarians significantly increase overall treatment expenses. These costs can limit access, particularly in price-sensitive regions and among uninsured pet owners. Despite rising awareness, affordability challenges continue to restrict widespread adoption of specialty services, especially in emerging markets with limited pet insurance penetration.
Advancements in veterinary medicine
Continuous advancements in veterinary medicine present significant growth opportunities for the market. Innovations in diagnostic imaging, minimally invasive surgeries, regenerative medicine, and targeted therapeutics are improving treatment outcomes for complex animal health conditions. Additionally, the integration of digital health tools, teleconsultations, and AI-assisted diagnostics is enhancing clinical efficiency and accuracy. These advancements are expanding the scope of specialty care and encouraging greater adoption among veterinary professionals and pet owners.
Regulatory and compliance challenges
Regulatory and compliance challenges pose a notable threat to the small animal specialty care market. Veterinary practices must adhere to stringent standards related to medical procedures, drug usage, data management, and animal welfare, which can vary significantly across regions. Frequent regulatory updates increase operational complexity and compliance costs for specialty hospitals. Failure to meet these requirements can result in penalties or service limitations, potentially hindering market expansion and cross border service delivery.
The COVID-19 pandemic had a mixed impact on the Small Animal Specialty Care Market. While initial lockdowns disrupted veterinary visits and elective procedures, the pandemic also led to a surge in pet adoption and heightened focus on pet health. Over time, demand for specialty care rebounded strongly, supported by deferred treatments and increased pet ownership. Veterinary practices adopted telemedicine and enhanced safety protocols, accelerating digital transformation within the specialty care ecosystem.
The dermatology segment is expected to be the largest during the forecast period
The dermatology segment is expected to account for the largest market share during the forecast period, due to the high prevalence of skin-related conditions in companion animals. Allergies, infections, parasitic infestations, and chronic dermatological disorders are common among dogs and cats, driving frequent veterinary consultations. Increasing awareness, improved diagnostic capabilities, and the availability of advanced topical and systemic therapies further supports the dominance of this segment in specialty veterinary care.
The surgical services segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the surgical services segment is predicted to witness the highest growth rate, due to rising demand for advanced and minimally invasive procedures. Growth is supported by technological advancements in surgical equipment, anesthesia, and post operative care, which improve safety and outcomes. Increasing cases of trauma, orthopedic disorders, cancer, and congenital abnormalities in small animals are also contributing to higher adoption of specialized surgical interventions.
During the forecast period, the North America region is expected to hold the largest market share, due to high pet ownership rates, well-established veterinary infrastructure, and strong adoption of advanced specialty services. The presence of leading veterinary hospitals, widespread availability of board-certified specialists, and high awareness among pet owners support market dominance. Additionally, favorable pet insurance coverage and higher disposable income levels further drive demand for premium specialty care services in the region.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to rapid urbanization, increasing pet adoption, and rising disposable incomes. Growing awareness of animal health, expansion of veterinary specialty clinics and improving access to advanced medical technologies are fueling market growth. Additionally, evolving cultural attitudes toward pets and increasing investments in veterinary healthcare infrastructure are accelerating the adoption of small animal specialty care across the region.
Key players in the market
Some of the key players in Small Animal Specialty Care Market include Zoetis Inc., Merck Animal Health (Merck & Co., Inc.), Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., IDEXX Laboratories, Inc., Ceva Sante Animale, Virbac S.A., Vetoquinol S.A., Dechra Pharmaceuticals PLC, Mars Veterinary Health, PetIQ, Inc., Phibro Animal Health Corporation, Neogen Corporation, PetVet Care Centers LLC and MedVet.
In October 2025, Mars and Big Idea Ventures have hand-picked three innovative startups for their 2025 Next Generation Pet Food Program, spotlighting sustainable biotech ingredients and circular feed solutions to transform pet nutrition and reduce environmental impact.
In March 2025, Mars, has extended its partnership with the Washington Spirit, becoming the team's Official Petcare Partner, with its logo featured on jerseys and signage, community ticket donations, pet-friendly game nights, and collaborative fan and pet experiences.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.